Novartis, Pear collaborate on digital therapeutics

Pear Therapeutics Inc. (Boston, Mass.) and Novartis AG (NYSE:NVS; SIX:NOVN) partnered to develop Pear's THRIVE technology as a prescription digital

Read the full 205 word article

User Sign In